The paradox of SMURF-less outcomes and its implication for diabetes

Edina Cenko1, Olivia Manfrini1,2, Jinsung Yoon3

  • 1Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti 9, Bologna 40138, Italy.

Abstract

Insights

Diabetes independently increases 30-day mortality risk in acute coronary syndromes (ACS). Combining diabetes with other modifiable risk factors masks this increased risk, necessitating individualized assessments.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Acute coronary syndromes (ACS) paradoxically show higher mortality in individuals without standardized modifiable risk factors (SMuRF), including those with diabetes.
  • The independent impact of diabetes on post-ACS mortality requires clarification.
  • Grouping diabetes with other SMuRF may obscure its true effect on mortality.

Purpose of the Study:

  • To determine the independent effect of diabetes on 30-day mortality after ACS.
  • To investigate how combining diabetes with other SMuRF influences observed mortality risks.

Main Methods:

  • Analysis of 70,953 first-time ACS patients.
  • Utilized inverse probability weighting for confounding adjustment.
  • Primary outcome: 30-day mortality post-ACS.

Main Results:

  • Diabetic patients without other SMuRF had significantly higher 30-day mortality (RR 1.29 women, 1.40 men).
  • Combining diabetes with other SMuRF diluted its impact on mortality.
  • Specific RRs for diabetic patients with smoking, hypercholesterolemia, or hypertension showed varied effects, often masking the independent risk.

Conclusions:

  • Diabetes is an independent risk factor for increased 30-day mortality in ACS patients.
  • Aggregating diabetes with other SMuRF leads to dilution bias, masking the true mortality risk.
  • Individualized risk factor assessment is crucial for managing ACS patients with diabetes.

Related Concept Videos

Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.8K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.5K
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.8K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
498